Global Pharma Industry Eyes Faster Patient Access with EU Regulatory Overhaul

The European Union has reached a landmark agreement to reform drug regulations, aiming to speed up patient access to medicines across the bloc. The new framework revises data and market exclusivity rules, supports antibiotic innovation, and strengthens supply security. Industry analysts say the changes could reshape competition in the European pharma market, while critics caution that shorter exclusivity periods may impact incentives for drug development.